Alignment Healthcare, Inc. cash flow to debt ratio of 41.39% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Alignment Healthcare, Inc.'s free cash flow has increased -1.80K% from $-6.65M last year to $113.15M, signaling increasing performance

Alignment Healthcare, Inc.'s debt to equity ratio is 1.59, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy

Alignment Healthcare, Inc.'s debt has decreased relative to shareholder equity from 3.30 last year to 1.59 today, signaling strengthened financials

Alignment Healthcare, Inc. has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Alignment Healthcare, Inc.'s interest coverage ratio of 2.24 indicates that earnings with margin can cover interest payments on company debt

Alignment Healthcare, Inc.'s profit margin has increased (-109.83%) in the last year from -4.74% to 0.47%, signaling increasing performance

Alignment Healthcare, Inc.'s short-term assets of $831.14M exceed its short-term liabilities of $476.53M

Alignment Healthcare, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Alignment Healthcare, Inc.'s return on equity of 11.50%, is lower than 15.00%, indicating bad performance

Alignment Healthcare, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Alignment Healthcare, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings

Alignment Healthcare, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Alignment Healthcare, Inc. has a free cash flow yield of 2.58%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Alignment Healthcare, Inc.'s yearly earnings has increased -99.43% since last year from $-128.03M to $-724.00K, signaling increasing performance

Alignment Healthcare, Inc.'s yearly revenue has increased 46.06% since last year from $2.70G to $3.95G, signaling increasing performance

ROIC 5.88% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Alignment Healthcare, Inc.'s 3-year revenue CAGR of 40.16% is positive, indicating growing revenue over the past 3 years

Alignment Healthcare, Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance

Alignment Healthcare, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

Alignment Healthcare, Inc. has insufficient data to evaluate this check.

Alignment Healthcare, Inc. has an earnings yield of 0.45%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Alignment Healthcare, Inc. is overvalued relative to its fair value price of 2.73 based on EBITDA multiple model

Alignment Healthcare, Inc. has an EV/EBITDA ratio of 91.41x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Alignment Healthcare, Inc. is overvalued relative to its fair value price of -27.05 based on Earnings Fair Value model

Alignment Healthcare, Inc. has a PEG-ratio under 1 which is considered undervalued

Alignment Healthcare, Inc. has a price-to-book ratio of 21.04x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Alignment Healthcare, Inc. has a price-to-sales ratio of 1.02x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue